139 related articles for article (PubMed ID: 21254017)
41. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N
Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638
[TBL] [Abstract][Full Text] [Related]
42. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
Guiu B; Petit JM; Bonnetain F; Ladoire S; Guiu S; Cercueil JP; Krausé D; Hillon P; Borg C; Chauffert B; Ghiringhelli F
Gut; 2010 Mar; 59(3):341-7. PubMed ID: 19837679
[TBL] [Abstract][Full Text] [Related]
43. Postoperative liver function after elective right hepatectomy in elderly patients.
Ettorre GM; Sommacale D; Farges O; Sauvanet A; Guevara O; Belghiti J
Br J Surg; 2001 Jan; 88(1):73-6. PubMed ID: 11136314
[TBL] [Abstract][Full Text] [Related]
44. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab.
Stremitzer S; Stift J; Gruenberger B; Tamandl D; Aschacher T; Wolf B; Wrba F; Gruenberger T
Br J Surg; 2012 Nov; 99(11):1575-82. PubMed ID: 23027075
[TBL] [Abstract][Full Text] [Related]
45. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
46. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
[TBL] [Abstract][Full Text] [Related]
47. Liver resection for colorectal cancer metastases involving the caudate lobe.
Thomas RL; Lordan JT; Devalia K; Quiney N; Fawcett W; Worthington TR; Karanjia ND
Br J Surg; 2011 Oct; 98(10):1476-82. PubMed ID: 21755500
[TBL] [Abstract][Full Text] [Related]
48. Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy.
Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T; Hanaoka J; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Asanoma M; Takasu C; Bando Y
Anticancer Res; 2014 Apr; 34(4):1953-8. PubMed ID: 24692731
[TBL] [Abstract][Full Text] [Related]
49. The extent of resection influences outcome following hepatectomy for colorectal liver metastases.
Stewart GD; O'Súilleabháin CB; Madhavan KK; Wigmore SJ; Parks RW; Garden OJ
Eur J Surg Oncol; 2004 May; 30(4):370-6. PubMed ID: 15063889
[TBL] [Abstract][Full Text] [Related]
50. Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients.
Adam R; Yi B; Innominato PF; Barroso E; Laurent C; Giuliante F; Capussotti L; Lapointe R; Regimbeau JM; Lopez-Ben S; Isoniemi H; Hubert C; Lin JK; Gruenberger T; Elias D; Skipenko OG; Guglielmi A;
Eur J Cancer; 2017 Jun; 78():7-15. PubMed ID: 28407529
[TBL] [Abstract][Full Text] [Related]
51. [Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab].
Sugiyama M; Kakeji Y; Kubo N; Nakanoko T; Fujinaka Y; Ando K; Masuda T; Yagi K; Yoshinaga K; Saeki H; Endo K; Emi Y; Morita M; Maehara Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2169-71. PubMed ID: 20037359
[TBL] [Abstract][Full Text] [Related]
52. Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival.
Gruenberger T; Arnold D; Rubbia-Brandt L
Surg Oncol; 2012 Dec; 21(4):309-15. PubMed ID: 22884035
[TBL] [Abstract][Full Text] [Related]
53. Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study.
Mahfud M; Breitenstein S; El-Badry AM; Puhan M; Rickenbacher A; Samaras P; Pessaux P; Lopez-Ben S; Jaeck D; Figueras J; Alain-Clavien P
World J Surg; 2010 Jan; 34(1):92-100. PubMed ID: 19838754
[TBL] [Abstract][Full Text] [Related]
54. Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.
Kornprat P; Schöllnast H; Cerwenka H; Werkgartner G; Bernhardt G; Mischinger HJ
Int J Colorectal Dis; 2009 Jan; 24(1):125-6. PubMed ID: 18682963
[No Abstract] [Full Text] [Related]
55. Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.
Margonis GA; Buettner S; Andreatos N; Sasaki K; Pour MZ; Deshwar A; Wang J; Ghasebeh MA; Damaskos C; Rezaee N; Pawlik TM; Wolfgang CL; Kamel IR; Weiss MJ
J Surg Oncol; 2017 Dec; 116(8):1150-1158. PubMed ID: 28743167
[TBL] [Abstract][Full Text] [Related]
56. Sclerosing cholangitis in the era of target chemotherapy: a possible anti-VEGF effect.
Delis S; Triantopoulou C; Bakoyiannis A; Tassopoulos N; Athanasiou K; Dervenis C
Dig Liver Dis; 2009 Jan; 41(1):72-7. PubMed ID: 18294938
[TBL] [Abstract][Full Text] [Related]
57. Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
Eefsen RL; Engelholm L; Willemoe GL; Van den Eynden GG; Laerum OD; Christensen IJ; Rolff HC; Høyer-Hansen G; Osterlind K; Vainer B; Illemann M
Int J Cancer; 2016 Apr; 138(7):1777-84. PubMed ID: 26510166
[TBL] [Abstract][Full Text] [Related]
58. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases.
Yamashita S; Shindoh J; Mizuno T; Chun YS; Conrad C; Aloia TA; Vauthey JN
J Hepatol; 2017 Jul; 67(1):56-64. PubMed ID: 28192187
[TBL] [Abstract][Full Text] [Related]
59. Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
Poultsides GA; Bao F; Servais EL; Hernandez-Boussard T; DeMatteo RP; Allen PJ; Fong Y; Kemeny NE; Saltz LB; Klimstra DS; Jarnagin WR; Shia J; D'Angelica MI
Ann Surg Oncol; 2012 Sep; 19(9):2797-804. PubMed ID: 22476753
[TBL] [Abstract][Full Text] [Related]
60. [Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?].
Zalinski S; Bigourdan JM; Vauthey JN
J Chir (Paris); 2010 Jan; 147 Suppl 1():S18-24. PubMed ID: 20172201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
